Login to Your Account

AACR Data Point to Profitable Path for Molecular Diagnostics

By Trista Morrison

Monday, April 27, 2009
In a plenary talk about cancer genomics at last week's 100th Annual Meeting of the American Association for Cancer Research, Eric Lander, founding director of the Broad Institute, said he hopes to see complete cancer genome analyses become a routine part of oncology research within five years and a standard of care for patients within 10 years.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription